In recent years, it has emerged that members of the IL-17 family are crucially involved in the pathogenesis of some subtypes of JIA, confirming that both oJIA and pJIA patients have a large amount of this cytokine in the active phase of the disease [14]. This evidence concerns the gene IL17A and juvenile idiopathic arthritis.